Obesity and type 2 diabetes patients show a decreased serum adiponectin level and low-grade chronic inflammation associated with an increased production of pro-inflammatory cytokines like IL-6 and TNF-α [88]. Here, ADIPOQ is linked to type 2 diabetes mellitus.